XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 795.2 $ 894.8
Marketable investments 1,460.0 1,035.9
Accounts receivable, no allowance for 2022 and 2021 173.4 198.7
Inventories, net 89.9 93.8
Other current assets 165.8 100.4
Total current assets 2,684.3 2,323.6
Marketable investments 1,641.9 1,649.9
Goodwill and other intangible assets, net 44.6 44.6
Property, plant, and equipment, net 791.4 780.9
Deferred tax assets, net 275.3 261.9
Other non-current assets 105.8 108.2
Total assets 5,543.3 5,169.1
Current liabilities:    
Accounts payable and accrued expenses 196.6 174.6
Share tracking awards plan 95.3 102.4
Other current liabilities 39.6 28.4
Total current liabilities 331.5 305.4
Line of credit 800.0 800.0
Other non-current liabilities 93.4 104.8
Total liabilities 1,224.9 1,210.2
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, par value $.01, 10,000,000 shares authorized, no shares issued 0.0 0.0
Common stock, par value $.01, 245,000,000 shares authorized, 72,109,175 and 71,727,021 shares issued, and 45,489,959 and 45,107,805 shares outstanding at June 30, 2022 and December 31, 2021, respectively 0.7 0.7
Additional paid-in capital 2,291.5 2,245.4
Accumulated other comprehensive loss (65.5) (23.0)
Treasury stock, 26,619,216 shares at June 30, 2022 and December 31, 2021 (2,579.2) (2,579.2)
Retained earnings 4,670.9 4,315.0
Total stockholders’ equity 4,318.4 3,958.9
Total liabilities and stockholders’ equity $ 5,543.3 $ 5,169.1